Pyroptotic T cell-derived active IL-16 has a driving function in ovarian endometriosis development

Cell Rep Med. 2024 Mar 19;5(3):101476. doi: 10.1016/j.xcrm.2024.101476.

Abstract

Endometriosis, affecting 6%-10% of women, often leads to pain and infertility and its underlying inflammatory mechanisms are poorly understood. We established endometriosis models in wild-type and IL16KO mice, revealing the driver function of IL-16 in initiating endometriosis-related inflammation. Using an in vitro system, we confirmed iron overload-induced GSDME-mediated pyroptosis as a key trigger for IL-16 activation and release. In addition, our research led to the development of Z30702029, a compound inhibiting GSDME-NTD-mediated pyroptosis, which shows promise as a therapeutic intervention for endometriosis. Importantly, our findings extend beyond endometriosis, highlighting GSDME-mediated pyroptosis as a broader pathway for IL-16 release and offering insights into potential treatments for various inflammatory conditions.

Keywords: GSDME; IL-16; endometriosis; infertility; inflammation; interleukin-16; iron overload; ovarian endometriosis; pyroptosis.

MeSH terms

  • Animals
  • Endometriosis* / drug therapy
  • Female
  • Humans
  • Inflammation
  • Interleukin-16
  • Mice
  • Pyroptosis
  • T-Lymphocytes

Substances

  • Interleukin-16
  • Il16 protein, mouse